Clinical trial Recruiting at 1 site Interventional Ages 18 and up

EUS-directed transenteric ERCP to reach an inaccessible papilla or biliodigestive anastomosis

Official title: EUS-directed Transenteric ERCP (EDEE) in Patients With Benign and Malignant Underlying Conditions and Inaccessible Papilla/Biliodigestive Anastomosis (BDA)

Run by Evangelisches Krankenhaus Düsseldorf · NCT07096895 · Data updated 2026-11-12

This will try EUS-directed transenteric ERCP to reach and treat blocked bile ducts in adults whose papilla or biliodigestive anastomosis cannot be reached by conventional endoscopy or enteroscopy.

More Gastric Outlet Obstruction trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment40 (estimated)
SponsorEvangelisches Krankenhaus Düsseldorf
Academic / other
Locations1 site (Düsseldorf)
StatusRecruiting
StartedFebruary 1, 2020
Main results expectedJanuary 1, 2027
Study endsJanuary 1, 2027
Registry record updatedJuly 31, 2025
Trial IDNCT07096895 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (age >18) who need biliary intervention but whose papilla or biliodigestive anastomosis cannot be reached by conventional endoscopy or enteroscopy and who can give informed consent are ideal candidates.

Probably not a fit

Patients who can be treated with standard ERCP or enteroscopy-assisted ERCP, those with contraindications to EUS or endoscopy, or those requiring interventions not suitable via a transenteric route (for example certain right-sided biliary anatomies) may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Patients with surgically altered anatomy or malignant gastric outlet obstruction can have an unreachable papilla or biliodigestive anastomosis, which makes conventional ERCP impossible and often leads to percutaneous drains. This interventional protocol uses endoscopic ultrasound to create a transenteric access route and then performs ERCP through that route (EDEE) as a single-session internal biliary approach. The main focus is on procedure safety and technical/clinical success in adults who consent and require biliary intervention when standard approaches fail. The study is being conducted at a single center in Düsseldorf and enrolls patients age 18 and older.

Why it matters

Potential benefit: If successful, EDEE could provide internal biliary drainage and treatments that avoid external drains and repeated percutaneous procedures, improving comfort and quality of life.

How similar studies have gone: Other EUS-guided biliary access techniques have reported high technical success rates (around 90%) but EDEE as a directed transenteric ERCP approach is less widely studied and remains somewhat novel for complex interventions.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* signed consent form
* Indication for an EDEE
* Age \>18 years

Exclusion Criteria:

* Age \< 18 years

Where it's running

  • Evangelisches Krankenhaus Düsseldorf
    Düsseldorf, Germany
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.